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Abstract
Background: The aim of this case report is to introduce the combined use of brush biopsy and
measurement of MAGE-A expression in the diagnosis of oral squamous cell carcinoma (OSCC).
Case report: We report of a 49-year old male patient who was referred to our department with
a persistent-suspicious looking leukoplakia. Brush biopsy and an incisional biopsy were performed
following clinical diagnosis. Histopathological examination revealed no malignancy. Expression
analysis of melanoma-associated antigens A (MAGE-A) using real time RT-PCR was applied to
brush biopsy materials because of the high prevalence of MAGE-A determined previously in
OSCC's. Results indicated significant MAGE-A3 and A4 expression pattern. Therefore, the lesion
was excised completely and an early invasive carcinoma was identified.
Conclusion: These results emphasize the role of brush biopsy using a tumor marker with a high
expression frequency combined with a high sensitive and high specific detection system in the early
diagnosis of OSCC, particularly in widespread leukoplakias.
Introduction
Early detection of oral squamous cell carcinoma (OSCC)
at an early stage improves the five-year patient survival
rate to approximately 80%. Therefore, early diagnosis is
the most effective approach for reducing morbidity and
mortality. In routine follow-up, the oncologists and the
head and neck surgeons are often confronted with suspi-
cious and even non-suspicious lesions of the oral mucosa,
especially in pitted areas after tumor resection or post-
radiation within a long observation period. Over the past
decades, adjunctive methods have emerged to facilitate
the diagnosis of premalignant and malignant oral lesions
[1]. Until now, incisional biopsy and histopathological
evaluation have been the most accurate and reliable meth-
ods for diagnosing suspicious oral lesions [2]. His-
topathological diagnosis and the following surgical and/
or radiochemotherapeutical approach depend on subjec-
tive recognition, identification of the most appropriate
site of the ambiguous oral lesion and sufficient sampling.
Therefore, incisional biopsy may have some limitations,
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especially in widespread lesions or areas with no clinical
evidence of histopathological changes or molecular alter-
ations (e.g. field cancerization) [3-5].
The current literature shows several adjunctive sampling
and diagnostic techniques for gaining knowledge about
the malignant differentiation and transformation of the
oral epithelium [1,6]. In the past decade, brush biopsy of
oral mucosal lesions has aroused new interest as a non-
invasive cell sampling method and various new tech-
niques for cytological analysis have been developed.
Despite the wide use of this technique, conventional exfo-
liative cytology method displayed a limited sensitivity of
between 79% to 97% and specificity from 95.1% to
99.5% [7]. Although promising analytical efforts to mini-
mize false positive and negative results using this method
have previously been made, it still has some drawbacks
[7,8]. However, until now the early detection of malig-
nant transformation of the oral mucosal lesions, espe-
cially in apparently innocuous lesions, has remained a
problem [9]. Therefore, this case report aimed to advance
the methodical diagnosis of exfoliative cytology in oral
cancer using an objective high prevalent tumor marker in
combination with a high sensitive and specific molecular
detection analysis. Therefore, the present case report
sought to introduce the combined use of brush biopsy
and measurement of MAGE-A expression for the diagno-
sis of OSCC.
Case report
A 49-year old patient was referred to the Department of
Oral and Maxillofacial Surgery at the University of Erlan-
gen-Nuremberg following OSCC of the left floor of the
mouth, including the partial resection of the mandible,
neck dissection and local reconstruction. The histopatho-
logical examination displayed pT1 pN0 cM0 G2 R0 status.
Adjuvant radiotherapy was not carried out because of the
low invasion depth of 3 mm. Patient was closely moni-
tored during regular follow-up intervals. Five months
later, leukoplakia at the patient's left palatoglossal arch
was diagnosed (Figure 1). No induration was palpable.
Subsequently, the lesion was biopsied by scalpel at the
most suspicious site. The histological examination of the
incisional biopsy showed a hyper- and parakeratosis
(thickening and keratinization characterized by the reten-
tion of nuclei of the stratum corneum), but no malig-
nancy (Figure 2). Additionally, this lesion was routinely
smeared using a commercially available cytobrush (Cyto-
brush® Plus GT, Medscand Medical AB, Sweden). Sam-
pling was made with a moderate pressure and permanent
rotation within the whole lesion in order to harvest cells.
The brush was then rolled out on a slide by taking care of
cell folding, air-dried and stained according to Papanico-
laou. The following histopathological analysis of the spec-
imen showed an epithelial dysplasia (atypical epithelial
cells with polygonal epithelial cells showing clear cyto-
plasm and isomorphic, oval, small nuclei) (Figure 3). For
further accuracy of methodical diagnosis of exfoliative
cytology, we established a highly sensitive multimarker
real time RT-PCR assay to detect the OSCC-related MAGE-
A genes using a brush biopsy. As a negative control,
healthy contralateral oral mucosa was smeared. The fol-
lowing molecular analysis revealed a significant increase
of MAGE-A3 and A4 expression in the leukoplakia in con-
trast with the healthy oral mucosa where no MAGE-A
expression profile was determined (Figure 4 and 5). A sur-
gical resection and further histopathological examination
was finally performed which revealed an early invasive
carcinoma of the oral mucosa (Figure 6).
Materials and methods
Isolation of RNA
Total RNA was extracted from cells harvested by cytobrush
using the RNA-Bee extraction method according to the
manufacturer's protocol (AMS Biotechnology, Europe). In
Leukoplakia at the left palatoglossal arch Figure 1
Leukoplakia at the left palatoglossal arch.
Hyper- and parakeratosis (H&E, oil immersion, 630-fold mag- nification) Figure 2
Hyper- and parakeratosis (H&E, oil immersion, 630-
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addition, RNA quality and quantity was assessed by the
"Lab-ona-Chip" method (Bioanalyzer 2100; Agilent Tech-
nologies, Palo Alto, CA) according to the manufacturer's
instructions.
The quality of RNA was assessed using the One Step RT-
PCR Kit (Qiagen, Hilden, Germany), amplifying cDNA
using glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH)-specific primers and analyzing the GAPDH-
PCR products on a 2% agarose gel. To exclude the false
positive results generated by amplifying genomic DNA
sequences that were not totally eliminated by DNA diges-
tion, purified RNA from each specimen was tested for
amplification of genomic GAPDH using the specific prim-
ers for PCR. GAPDH-PCR products were then analyzed on
a 2% agarose gel. Only RNA isolations showing the spe-
cific amplification product in RT-PCR and no visible band
for genomic amplifications were analyzed for the subse-
quent procedures. All the incisional biopsies and cytolo-
gies were investigated by the Institute of Pathology at the
University of Erlangen-Nuremberg.
Reverse transcription and real time PCR
cDNAs from the total RNA were synthesized using the
High Capacity cDNA Archive Kit (Cat. 4322171; Applied
Biosystems, CA, USA) according to the manufacturer's
protocol. Real time RT-PCR analyses were done using
QuantiTect Primer Assays (Qiagen; [Hs_QT01841224
QuantiTect Primer Assay] for MAGE-A3 and [Hs_
QT01841225 QuantiTect Primer Assay] for MAGE-A4).
For normalization, GAPDH was used
[Hs_GAPDH_QT000792471 QuantiTect Primer Assay].
The detection of mRNA was performed with the ABI Prism
7300 Sequence Detection System (Applied Biosystems,
Weiterstadt, Germany). The QuantiTect TM SYBR® green
PCR kit (Cat. 204143; Qiagen) was used for PCR amplifi-
cation. Briefly, 50 ng of cDNA was used for each PCR reac-
tion in a total volume of 25 μl. The cycling conditions
Atypical epithelial cells with polygonal epithelial cells showing  clear cytoplasm and isomorphic, oval, small nuclei (Papanico- laou stain, oil immersion, 630-fold magnification) Figure 3
Atypical epithelial cells with polygonal epithelial cells 
showing clear cytoplasm and isomorphic, oval, small 
nuclei (Papanicolaou stain, oil immersion, 630-fold 
magnification).
Expression analysis of MAGE-A3 and -A4 by real time RT-PCR, NOM* (Normal oral mucosa); Rn represents the raw flures- cence signal over time Figure 4
Expression analysis of MAGE-A3 and -A4 by real time RT-PCR, NOM* (Normal oral mucosa); Rn represents 
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used for the real time PCR were as follows: initial denatur-
ation/enzyme activation for 15 min at 95°C followed by
40 cycles of denaturation at 94°C for 15 s, annealing at
55°C for 30 s and elongation at 72°C for 34 s. The ampli-
fication and presence of a specific product was verified by
melting curve analysis after PCR. A Ct value < 33 was rec-
ommended as a positive for the expression of the target
gene. All the reactions were run in triplet and verified by a
second analysis. Results are displayed in Fig. 4. Formation
of undesired side products during PCR that contribute to
fluorescence was assessed by melting curve analysis after
PCR.
Discussion
Despite the continuous improvements in surgical recon-
struction and radiochemotherapy regimens, early detec-
tion and diagnosis of OSCC is still the most effective
approach for reducing morbidity and mortality.
Clinical inspection of the oral cavity is not sensitive
enough in identifying premalignant and malignant
lesions [7,10,11]. Until now, tissue harvesting by scalpel
biopsy and subsequent histological examination have
been the gold standard for diagnosing premalignant and
malignant oral diseases. Consequently, adequate clinical
intervention should be based on histopathological find-
ings of the lesion. It is evident that incision biopsies taken
of suspicious lesions, which have a limited reproducibility
within the whole lesion [4], may result in a more or less
aggressive surgical and/or radiochemotherapeutic
approach. An inter- and intraobserver variability of histo-
logical diagnoses was even described by several authors
[12,13]. Therefore, identifying further diagnostic tools
Expression analysis of MAGE-A3 and -A4 by real time RT-PCR, NOM* (Normal oral mucosa); Rn represents the raw flures- cence signal over time Figure 5
Expression analysis of MAGE-A3 and -A4 by real time RT-PCR, NOM* (Normal oral mucosa); Rn represents 
the raw flurescence signal over time.
Early carcinoma (H&E, oil immersion, 400-fold magnification) Figure 6
Early carcinoma (H&E, oil immersion, 400-fold mag-
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remains crucial for receiving the most representative anal-
ysis of any suspicious lesions.
Oral cytology, as an adjunctive non-invasive sampling
technique, is becoming increasingly important in the
early diagnosis and monitoring of precursor lesions and
oral cancer. Transepithelial 'field mapping biopsies'
within widespread lesions are even more essential for
cytological evaluation and further investigation [14].
The diagnostic accuracy of the brush biopsy approach can
be significantly increased by molecular tumor marker
analysis, which reduces false negative diagnosis due to
insufficient diagnostic material [7]. Malignant epithelial
transformation is considered a process of multiple genetic
and epigenetic alterations which plays an important role
in tumorigenesis. Cellular changes occur at the molecular
level before appearing at the clinical site or in the patho-
histological examination, which makes them essential
additive tools for diagnosing cell development and trans-
formation [15,16]. Even high grade dysplasia implies an
established predictive prognostic marker for malignant
transformation, while low and moderate grade dysplasia
still have an unknown risk of further malignant transfor-
mation [5]. These entities, however, should also be pre-
dicted by the combination of histopathological and
molecular changes [17] to ensure correct risk assessment.
Early identification of premalignant and malignant
molecular cellular changes with a result of early interven-
tion may reduce treatment extent, morbidity and mortal-
ity.
In this study, we used MAGE-A3 and A4 encoding genes
which are expressed in various tumor types while geneti-
cally silent in all normal tissues except testis, placenta and
fetal tissues [18]. In the current literature, the multiple
expression of MAGE-A antigens in OSCC have been
described by several authors [19-22]. Our study group has
described a high summative expression pattern of the
melanoma antigens (MAGE-A1-A6 and -A12) of more
than 93% in OSCC [23,24]. Thus, the detection of these
markers, which are highly specific to cellular malignancy,
makes them potential markers for early diagnosis and
prognosis, and even a target for immunotherapy. We used
the real time RT-PCR assay, which detects even small
amounts of MAGE-RNA [25,26]. In this case report, we
further combined these highly prevalent tumor markers
with this sensitive detection method using brush biopsy
material for the early diagnosis of OSCC.
Therefore, this method presents a novel approach to the
early detection of OSCC patients with high risk (e.g., after
an initial diagnosis, tobacco and/or alcohol abuse). Addi-
tionally, it is an important aid for further diagnosis and
treatment of apparently innocuous oral lesions with an
unpredictable malignant transformation rate [11]. This
method is transferable to all other tumor markers and
tumor entities as it represents a promising alternative to
various oncological screening settings.
The malignant tissue alteration of the presented suspi-
cious lesion was uncovered by identifying the high preva-
lent tumor markers in combination with a high sensitive
and specific molecular detection analysis using brush
biopsy material.
Conclusion
Sole morphologic interpretations of histopathological
alterations of premalignant and malignant lesions and
their predictive malignant risk assessment will become
insufficient in the future. Objective techniques, especially
in conflicting cytopathological findings, will be necessary
for further information about the grade and course of epi-
thelial transformation to assure adequate clinical treat-
ment. Therefore, this novel approach may be the first step
to increase sensitivity and specificity and even facilitating
objectivity in the early diagnosis of just a few malignant
cells.
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